Introduction
============

Viruses play an important evolutionary role as vectors for horizontal gene transfer (HGT) in the genomes of theirs hosts. For example, integrated virus genomes are commonly found in prokaryotes, as prophages can constitute 10--20% of bacterial genomes ([@evw300-B5]; [@evw300-B8]), which serve as vectors for HGT between bacteria and contribute to the genetic variability in several bacterial species ([@evw300-B36]; [@evw300-B37]). Among eukaryotes, RNA viruses are widespread, and HGT of their genetic material to cells may play significant roles in eukaryotic evolution ([@evw300-B25]; [@evw300-B33]). For example, in fungi, the integration of nonretroviral RNA virus genes contributes to the formation of genes ([@evw300-B50]). In addition to the transfer from viruses to host cells, HGT also occurs commonly from host cells to viruses and between viruses. For example, RNA-dependent RNA polymerases of dsRNA viruses appear to have origins in diverse lineages of positive-strand RNA viruses ([@evw300-B1]; [@evw300-B26]), and phylogenetic analysis suggests that many Mimivirus genes were acquired by HGT from the host organism or from bacteria that parasitize the same host ([@evw300-B35]). Another example of HGT from host to virus is illustrated by plant closteroviruses that encode homologs of heat shock protein, 70 kDa (Hsp70) ([@evw300-B15], [@evw300-B16]). In general, viruses do not encode Hsp70s but recruit host Hsp70s to aid virion assembly or genome replication ([@evw300-B9]; [@evw300-B23]). In the case of closteroviruses, the *hsp70* gene was probably acquired by a common ancestor through recombination with a host mRNA coding for Hsp70 ([@evw300-B15], [@evw300-B16]).

Even though HGT is a widespread key mechanism in virus evolution, strong selection against increasing genome sizes in viruses is an impediment to HGT ([@evw300-B21]; [@evw300-B63]; [@evw300-B60]). This impediment is especially important in RNA viruses that tend to have smaller genomes than DNA viruses. An exogenous sequence that is transferred must be accommodated into the genome of the recipient virus. We postulate that the accommodation of gene sequences could entail the regulation of expression levels, fine-tuning of interactions with other viral or host proteins, and the optimization of codon usage. However, exogenous sequences in a viral genome will generally have an appreciable fitness cost, typically resulting in the rapid loss of these exogenous sequences ([@evw300-B14]; [@evw300-B63]). When a new sequence that may potentially be beneficial for the virus is incorporated in the genome, a race against time begins: will the new sequence be accommodated or will it be purged? The high instability of viral genomes may therefore hinder evolutionary innovation, by shortsightedly purging elements that might have been beneficial in the longer term. Previous studies that highlighted instability of exogenous sequences used marker genes, as these sequences can reasonably be assumed to be unable to acquire functionality.

In this study, we experimentally explore the evolutionary fate of exogenous genes introduced into the genome of *Tobacco etch virus* (TEV; genus *Potyirus*; family *Potyviridae*), a plant RNA virus. We have simulated two possible HGT events by considering sequences with functions that could potentially be beneficial to the virus. The first event represents the acquisition of a heterologous gene that duplicates a function that was already present in TEV, thus generating functional redundancy. The second event adds a novel function to the viral genome.

The first HGT event duplicates the RNA-silencing suppression activity. Plant RNA viruses counteract the host plant's immune responses by encoding viral suppressors of RNA silencing (VSRs). Most plant RNA viruses encode at least one VSR, but others like the closteroviruses, criniviruses, and begomoviruses encode more than one ([@evw300-B13]; [@evw300-B10]). In the case of TEV, the multifunctional HC-Pro protein is the only VSR. HC-Pro can be divided into three regions: (i) an N-terminal region associated with aphid transmission, (ii) a C-terminal region associated with proteinase and VSR activities ([@evw300-B55]), and (iii) a central region implicated in many functions, including VSR activity ([@evw300-B38]). The silencing suppressor activity of HC-Pro is not always strong enough to nullify silencing effects on virus replication ([@evw300-B19]). Moreover, the VSR activity of this multifunctional protein may be subject to pleiotropic constraints, which arise due to its other functions. We have chosen to insert the *2b* gene from *Cucumber mosaic virus* (CMV; genus *Cucumovirus*, family *Bromoviridae*) into TEV genome. The multifunctional 2b protein is implicated in polyprotein cleavage, virulence, viral movement, aphid-borne transmission, and suppression of RNA silencing ([@evw300-B11], [@evw300-B12]; [@evw300-B30]; [@evw300-B20]; [@evw300-B44]). The addition of a second silencing suppressor to the TEV genome could have both immediate benefits for replication, as well as second-order evolutionary benefits. Immediate benefits could arise simply due to stronger silencing-suppression activity based upon complementary molecular mechanisms. Second-order benefits could occur during evolution because pleiotropic constraints on HC-Pro's other functions have been ameliorated by the introduction of the *2b* gene and these functions can therefore be improved.

The second genome reorganization event represents the acquisition of a function that was not originally present in TEV. We have chosen to add an *AlkB* domain. The AlkB protein is responsible for the repair of alkylation damage in DNA and RNA bases. Alkylating agents that produce this damage can be present in the environment and inside cells ([@evw300-B43]). Homologues of *AlkB* are widespread in eukaryotes and bacteria ([@evw300-B2]; [@evw300-B28]), as well as in plant RNA viruses ([@evw300-B2]). Although the overall sequence similarity among the *AlkB* family is low, a conserved domain exists characterized as the 2OG-Fe(II) oxygenase superfamily ([@evw300-B2]; [@evw300-B17]). The 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenases are a class of enzymes that commonly catalyze the oxidation of an organic substrate using a dioxygen molecule. The AlkB protein in plant RNA viruses is involved in the repair of methylation damage ([@evw300-B54]). The host plant may use methylation as a defense mechanism to inactivate viral RNAs. Therefore, it has been suggested that AlkB homologues are involved in counteracting this defense mechanism ([@evw300-B4]). However, selection for maintenance of the conserved *AlkB* domain could also involve environmental factors, such as the use of alkylating pesticides. *AlkB* domains are mainly found in plant viruses belonging to the *Flexiviridae* family, which are---like TEV---positive-sense single-stranded RNA viruses. Within the *Potyviridae* family, only one virus with an *AlkB* domain has been reported: *Blackberry virus Y* (BVY) ([@evw300-B49]). In BVY, *AlkB* is located within the *P1* serine protease gene. Interestingly, BVY lacks the N terminus of HC-Pro that is present in the potyvirus orthologs. This missing region is involved in silencing suppression and vector transmission in other potyviruses ([@evw300-B40]; [@evw300-B53]; [@evw300-B48]; [@evw300-B62]). These are important functions for a potyvirus, suggesting that AlkB has evolved to take over these functions in BVY. To test this idea in a model system, we have introduced the conserved AlkB domain within the P1 protein in TEV.

Whereas the newly introduced *AlkB* domain was rapidly purged from the TEV genome in our experimental setup, the functionally redundant *2b* gene was maintained for more than half a year of evolution. We then performed further experiments to show that *2b* is functional within the TEV genome, and even might be beneficial when the functional domain of HC-Pro related to RNA-silencing suppression is mutated.

Materials and Methods
=====================

Viral Constructs, Virus Stocks, and Plant Infections
----------------------------------------------------

The TEV genome used to generate the virus constructs was originally isolated from *Nicotiana tabacum* plants ([@evw300-B7]). In this study two different variants of TEV containing exogenous sequences were used. One of these virus variants, hereafter named TEV-2b, contains the *2b* gene from CMV. The other virus variant, hereafter named TEV-AlkB, contains a conserved domain, characterized as a 2OG-Fe(II) oxygenase domain isolated from *Nicotiana benthamiana*.

TEV-2b and TEV-AlkB were generated from cDNA clones constructed using plasmid pMTEVa, which consists of a TEV infectious cDNA (accession: DQ986288, including two silent mutations, G273A and A1119G) flanked by SP6 phage RNA promoter derived from pTEV7DA (GenBank: DQ986288). pMTEVa contains a minimal transcription cassette to ensure a high plasmid stability ([@evw300-B3]). The clones were constructed using standard molecular biology techniques, including polymerase chain reaction (PCR) amplification of cDNA with the high-fidelity Phusion DNA polymerase (Thermo Fisher Scientific), DNA ligation with T4 DNA ligase (Thermo Fisher Scientific) and transformation of *Escherichia coli* DH5α by electroporation. For generation of TEV-2b, the *2b* gene was PCR amplified using phosphorylated primers forward 5′-ATGGAATTGAACGTAGGTGCA-3′ and reverse 5′-TTGAAAGTAGAGGTTCTCTGTAGTGAAAGCACCTTCCGCCC-3′ containing spacers and a proteolytic cleavage site between *2b* and *CP*. The *2b* gene was first ligated into the smaller pTV3 plasmid that was opened with primers: forward 5′-TCAGGTACAGTGGGTGCTGGTGTTGAC-3′ and reverse 5′-CTGAAAATAAAGATTCTCAGTCGTTG-3′. The restriction enzymes *Sal*I and *Bgl*II were used to transfer the digestion product containing the *2b* gene to the pMTEVa plasmid. For generation of TEV-AlkB, RNA was isolated from *N. benthamiana* and subsequently the conserved *AlkB* domain from the alkylated DNA repair protein AlkB homolog 1 was amplified by reverse transcription-PCR with primers forward 5′-GCCGCGCGCTCTGGAGCACCCTTGGCTTGCAGTTTG-3′ and reverse 5′-GCGCGTCTCTTGCCATGGGTGAATACTTGTCTAATGTTGATATTG-3′. After A-tailing with Taq DNA polymerase (Roche), the PCR product was cloned into pTZ57R/T (Thermo Fisher Scientific). Restriction sites for *Esp*3I and *Pau*I were then used for insertion of the cloned *AlkB* domain into pMTEVa. Sanger sequencing confirmed the sequences of the resulting plasmids.

The plasmids of TEV-2b and TEV-AlkB were linearized by digestion with *Bgl*II prior to *in vitro* RNA synthesis using the mMESSAGE mMACHINE® SP6 Transcription Kit (Ambion), as described by [@evw300-B6]. The third true leaf of 4-week-old *N. tabacum* L. cv Xanthi *NN* plants was mechanically inoculated with 5 μg of transcribed RNA. All symptomatic tissue was collected 7 days post inoculation (dpi) and stored at −80°C as a viral stock.

Experimental Evolution
----------------------

For the serial passage evolution experiments, 500 mg homogenized stock tissue was ground into fine powder using liquid nitrogen and a mortar, and resuspended in 500 μl phosphate buffer (50 mM KH~2~PO~4~, pH 7.0, 3% polyethylene glycol 6000). From this mixture, 20 μl were then mechanically inoculated on the third true leaf of 4-week old *N. tabacum* plants. At least five independent replicates were performed for each virus variant. At the end of the designated passage duration (3 or 9 weeks), all leaves above the inoculated leaf were collected and stored at −80 ºC. For subsequent passages the frozen tissue was homogenized and a sample was ground and resuspended with an equal amount of phosphate buffer ([@evw300-B63]). Then, new *N. tabacum* plants were mechanically inoculated as described above. The plants were kept in a BSL-2 greenhouse at 24°C with 16 h light:8 h dark photoperiod.

RT-PCR
------

To determine the stability of the exogenous sequences, RNA was extracted from 100 mg homogenized infected tissue using the InviTrap Spin Plant RNA Mini Kit (Stratec Molecular). Reverse transcription (RT) was performed using MMuLV reverse transcriptase (Thermo Fisher Scientific) and the reverse primer 5′-CGCACTACATAGGAGAATTAG-3′ located in the 3′ untranslated region of the TEV genome. PCR was then performed with Taq DNA polymerase (Roche) and primers flanking the *2b* gene: forward 5′-TACGATATTCCAACGACTG-3′ and reverse 5′-GCAAACTGCTCATGTGTGG-3′, or the AlkB domain: forward 5′- GCAATCAAGCATTCTACTTC-3′ and reverse 5′-ATGGTATGAAGAATGCCTC-3′. PCR products were resolved by electrophoresis on 1% agarose gels.

Fitness Assays
--------------

The genome equivalents per 100 mg of tissue of the ancestral virus stocks and all evolved lineages were determined prior to subsequent fitness assays. The InviTrap Spin Plant RNA Mini Kit (Stratec Molecular) was used to isolate total RNA from 100-mg homogenized infected tissue. Real-time quantitative RT-PCR was performed using the One-Step SYBR PrimeScript RT-PCR Kit II (Takara), in accordance with manufacturer instructions, in a StepOnePlus Real-Time PCR System (Applied Biosystems). Specific primers for the CP gene were used: forward 5′-TTGGTCTTGATGGCAACGTG-3′ and reverse 5′-TGTGCCGTTCAGTGTCTTCCT-3′. The StepOne Software v.2.2.2 (Applied Biosystems) was used to analyze the data. The concentration of genome equivalents per 100 mg of tissue was then normalized to that of the sample with the lowest concentration, using phosphate buffer.

For the accumulation assays, 4-week-old *N. tabacum* plants were inoculated in the third true leaf with 50 μl of the normalized dilutions of ground tissue. For each ancestral and evolved lineage, at least three independent plant replicates were used. Leaf tissue was harvested 7 dpi. Total RNA was extracted from 100 mg of homogenized tissue. Virus accumulation was then determined by means of RT-qPCR for the *CP* gene of the ancestral and the evolved lineages. For each of the harvested plants, at least three technical replicates were used in the RT-qPCR.

To measure within-host competitive fitness, we used TEV carrying an enhanced green fluorescent protein (TEV-eGFP) ([@evw300-B3]) as a common reference competitor. TEV-eGFP has proven to be stable up to 6 weeks (using 1- and 3-week serial passages) in *N. tabacum* ([@evw300-B63]) and is therefore not subjected to appreciable eGFP loss during our 1-week competition experiments. All ancestral and evolved viral lineages were again normalized to the sample with the lowest concentration, and 1:1 mixtures of viral genome equivalents were made with TEV-eGFP. The mixture was mechanically inoculated on 4-week-old *N. tabacum* plants, using three independent plant replicates per viral lineage. The plant leaves were collected at 7 dpi, and stored at −80°C. Total RNA was extracted from 100 mg homogenized tissue. RT-qPCR for the *CP* gene was used to determine total viral accumulation, and independent RT-qPCR reactions were also performed for the *eGFP* gene sequence using primers forward 5′-CGACAACCACTACCTGAGCA-3′ and reverse 5′-GAACTCCAGCAGGACCATGT-3′. The ratio $\left( R \right)$ of the evolved and ancestral lineages to TEV-eGFP is then $R = \frac{n_{CP} - n_{eGFP}}{n_{eGFP}}$, where $n_{CP}$ and $n_{eGFP}$ are the RT-qPCR measured copy numbers of *CP* and *eGFP*, respectively. Within-host competitive fitness can then be estimated as $W = \operatorname{}\sqrt[t]{R_{t}/R_{0}}$, where $R_{0}$ is the ratio at the start of the experiment and $R_{t}$ the ratio after *t* days of competition ([@evw300-B6]). Note that the method for determining $R$ only works well when the frequency of the common competitor is below ∼0.75. This limitation was not problematic though, since in these experiments the fitness of the evolved virus populations remained the same or increased. The statistical analyses comparing the fitness between lineages were performed using R v.3.2.2 ([@evw300-B39]) and IBM SPSS version 23.

Generation and Infectivity of the HC-Pro FINK and AS13 Mutant Genotypes
-----------------------------------------------------------------------

The plasmids of TEV and TEV-2b were used to generate two different mutant genotypes in each of the background sequences. One mutant genotype, hereafter named FINK, consists of the G548U nucleotide substitution within *HC-Pro*, which results in the R183I amino acid change within the highly conserved FRNK box. The other mutant genotype, hereafter named AS13, consists of the A895C and A900C nucleotide substitutions within *HC-Pro*, which results in the E299A and D300A amino acid changes. The TEV and TEV-2b FINK mutant genotypes were generated by site-directed mutagenesis performed with the QuickChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies) on the original pMTEVa and pMTEVa-2b plasmids (described above). The primers used for mutagenesis are as follows: forward 5′-GCGCATTGGCCACCTTGGTTCTTTCATAAATAAAATCTCATCGAAGGCCCATGTG-3′ and reverse 5′-CACATGGGCCTTCGATGAGATTTTATTTATGAAAGAACCAAGGTGGCCAATGCGC-3′. To obtain the TEV and TEV-2b AS13 mutant genotypes, the *HC-Pro* gene of TEV was replaced by that of the AS13 mutant. For this, an overlapping PCR product of ∼3 kb was generated, composed of: a 5′ fragment amplified with primers forward 5′-GGTGGAGCTCGTATGGCTTGC-3′ and reverse 5′-GTCAATCTCAGTGAAAAATCCTTTAAGAAACC-3′; a central sequence amplified with primers forward 5′-GGGGCCGATCTCGAAGAGGCAAGCACAC-3′ and reverse 5′- TCCTGTCGTTCTAGACCCATACGAATCC-3′; and a 3′ fragment amplified with primers forward 5′-GATAATGTCAACTGACTTCCAGACGCTCAGGC-3′ and reverse 5′- AGAATGTCAACAACAAGGAAAGGACACTCG-3′. The PCR products were digested with *Sna*BI and *Aat*II enzymes and then ligated into the pMTEVa and pMTEVa-2b plasmids previously opened with the same enzymes. Sanger sequencing confirmed the sequences of the resulting plasmids.

To test the viability of TEV^FINK^, TEV-2b^FINK^, TEV^AS13^, and TEV-2b^AS13^, the third true leaf of 4-week-old *N. tabacum* plants was mechanically inoculated with equal amounts of transcribed RNA. Two different assays were done. In a first one, plants were left to grow 20 dpi to observe the development of symptoms. In a second assay, all tissue was collected 10 dpi and stored at −80°C. RNA was extracted from 100 mg homogenized tissue using the Agilent Plant RNA Isolation Mini Kit (Agilent Technologies). As many plants did not show symptoms, RT-qPCR for the *CP* gene was performed to confirm infection and to determine viral accumulation levels of the different mutant genotypes. For those plants that were infected with sufficient viral accumulation levels to perform RT-PCR, Sanger sequencing was performed to confirm the sequences of the FINK and AS13 genotypes. RT was performed using MMuLV reverse transcriptase (Thermo Fisher Scientific) and the reverse primer 5′- TTGCACCTTGTGTGACCAC-3′, located in the *P3* gene. PCR was then performed with Phusion DNA polymerase (Thermo Fisher Scientific) and primers flanking the region of interest: forward 5′-GGGGCCGATCTCGAAGAGGCAAGCACAC-3′ and reverse 5′-GCAAAGAAAATGTTCATGTAGCAATAACCTTCATTAGCTATATACATT-3′. Sanger sequencing was performed at GenoScreen (Lille, France: [www.genoscreen.com](http://www.genoscreen.com); last accessed January 2, 2017) with an ABI3730XL DNA analyzer. Sequences were assembled using Geneious v.9.0.2 ([www.geneious.com](http://www.geneious.com); last accessed January 2, 2017).

Measurement of the Relative Expression of *NtAlkB*
--------------------------------------------------

The expression of the *AlkB* endogenous gene present in *N. tabacum*, hereafter referred to as *NtAlkB*, was measured by RT-qPCR. This measurement was done relative to two different reference genes: *L25*, encoding the ribosomal protein L25, and *EF1α*, encoding the translation elongation factor 1α ([@evw300-B41]). Total RNA was extracted from healthy plants and from plants infected with TEV and TEV-AlkB, respectively, at 7 dpi using three plant replicates each. To ensure that only the endogenous *NtAlkB* was amplified from TEV-AlkB-infected plants, primers outside the conserved domain were used. These primers were as follows: forward 5′-TTCTGCTTGGAGAGTCATCCAG-3′ and reverse 5′-TCTCCTTTATCCATCGGCACTG-3′. The *L25* reference gene was amplified using forward primer 5′-CCCCTCACCACAGAGTCTGC-3′ and reverse primer 5′-AAGGGTGTTGTTGTCCTCAATCTT-3′. The *EF1α* gene was amplified with forward and reverse primers 5′-TGAGATGCACCACGAAGCTC-3′ and 5′-CCAACATTGTCACCAGGAAGTG-3′, respectively.

Illumina Sequencing, Variants, and Single Nucleotide Polymorphisms Calling
--------------------------------------------------------------------------

For Illumina next-generation sequencing of the evolved and ancestral lineages, the viral genomes were amplified by RT-PCR using AccuScript Hi-Fi (Agilent Technologies) reverse transcriptase and Phusion DNA polymerase (Thermo Fisher Scientific), with six independent reactions that were pooled. Each virus was amplified using three primer sets generating three amplicons of similar size (set 1: 5′-GCAATCAAGCATTCTACTTCTATTGCAGC-3′ and 5′-TATGGAAGTCCTGTGGATTTTCCAGATCC-3′; set 2: 5′-TTGACGCTGAGCGGAGTGATGG-3′ and 5′-AATGCTTCCAGAATATGCC-3′; set 3: 5′-TCATTACAAACAAGCACTTG-3′ and 5′-CGCACTACATAGGAGAATTAG-3′). Equimolar mixtures of the three PCR products were made. Sequencing was performed at GenoScreen. Illumina HiSeq2500 2× 100 bp paired-end libraries with dual-index adaptors were prepared along with an internal PhiX control. Libraries were prepared using the Nextera XT DNA Library Preparation Kit (Illumina Inc.). Sequencing quality control was performed by GenoScreen, based on PhiX error rate and Q30 values.

Read artifact filtering and quality trimming (3′ minimum Q28 and minimum read length of 50 bp) was done using FASTX-Toolkit v.0.0.14 (<http://hannonlab.cshl.edu/fastx_toolkit/index.html>, last accessed January 2, 2017). Dereplication of the reads and 5′ quality trimming requiring a minimum of Q28 was done using PRINSEQ-lite v.0.20.4 ([@evw300-B42]). Reads containing undefined nucleotides (N) were discarded. As an initial mapping step, the evolved sequences were mapped using Bowtie v.2.2.6 ([@evw300-B29]) against their corresponding ancestral sequence: TEV (GenBank accession number KX137149), TEV-2b ancestral (GenBank accession number KX832616), and TEV-AlkB ancestral (GenBank accession number KX832617). Subsequently, mutations were detected using SAMtools' mpileup ([@evw300-B31]) in the evolved lineages as compared with their ancestral lineage. At this point, we were only interested in mutations at a frequency \> 10% and therefore, we present frequencies as reported by SAMtools, which has a low sensitivity for detecting low-frequency variants ([@evw300-B46]).

After the initial pre-mapping step, error correction was done using Polisher v2.0.8 (available for academic use from the Joint Genome Institute), and consensus sequences were defined for every lineage. Subsequently, the cleaned reads were remapped using Bowtie v.2.2.6 against the corresponding consensus sequence for every lineage. For each new consensus, single nucleotide polymorphisms (SNPs) within each virus population were identified using SAMtools' mpileup and VarScan v.2.3.9 ([@evw300-B24]). For SNP calling maximum coverage was set to 40,000 and SNPs with a frequency \< 1% were discarded.

Results and Discussion
======================

Introducing Functional Redundancy in TEV Genome: The 2b VSR
-----------------------------------------------------------

To simulate HGT between two virus species, we have introduced the 2b VSR from CMV into the TEV genome ([fig. 1*A*](#evw300-F1){ref-type="fig"}), between the *NIb* replicase gene and the *CP* ([fig. 1*B*](#evw300-F1){ref-type="fig"}). The C terminus of 2b was modified to provide a proteolytic cleavage site for NIa-Pro similar to that between NIb and CP in wild-type TEV. The introduction of *2b* generates functional redundancy within TEV, as the multifunctional HC-Pro protein also acts as a silencing suppressor. We postulated that the functionally redundant TEV-2b virus could go down different trajectories, depending on (i) the fitness effect of *2b* upon insertion into the TEV genome, (ii) whether or not the gene can be accommodated in the genome, and (iii) whether *2b* could be maintained because functional redundancy increases the mutational robustness of TEV, buffering the effects of deleterious mutations hindering the silencing suppressor activity. If the insertion of *2b* is immediately beneficial, or if accommodation of the gene into the TEV genome occurs quickly, *2b* could be maintained over evolutionary time. In this scenario, it is possible that 2b becomes entirely responsible for silencing suppression, taking over from HC-Pro and allowing it to specialize on one of its other functions.[Fig]{.smallcaps}. 1.---Schematic representation of the *Tobacco etch virus* genotypes with exogenous gene insertions. (*A*) The wild-type TEV codes for 11 mature peptides, including P3N-PIPO embedded within the P3 protein at a +2 frameshift. Relevant names of the protein products are indicated in the gray dotted boxes. (*B*) The *2b* gene from *Cucumber mosaic virus* was introduced between *NIb* and *CP*. The C terminus of 2b was modified to provide a similar proteolytic cleavage site for NIa-Pro as the one that originally existed between *NIb* and *CP*. (*C*) A conserved *AlkB* domain, similar to the one found in the host plant, was introduced within the *P1* gene.

When we evolved TEV-2b virus in *N. tabacum* plants, using 3-week and 9-week passages, we never detected any genomic deletions by RT-PCR. These results contrasts with all previous long-duration passage results for TEV, where deletions removing the added genetic material were quickly observed, regardless of it being a redundant gene copy ([@evw300-B59]a, [@evw300-B60]) or encoding for additional marker proteins ([@evw300-B14]; [@evw300-B63]). Therefore, we speculated that the TEV-2b virus might have a fitness advantage over the wild-type TEV. To test this hypothesis, we measured within-host competitive fitness and viral accumulation of the ancestral and evolved lineages. Additionally, we measured plant height as a proxy for virulence; healthy plants grow taller compared with plants infected with wild-type TEV. We found that the ancestral TEV and TEV-2b have a very similar within-host competitive fitness ([fig. 2*A*;](#evw300-F2){ref-type="fig"} *t*-test comparing ancestral viruses: *t* ~4 ~=~ ~2.008, *P* = 0.115), viral accumulation ([fig. 2*B*;](#evw300-F2){ref-type="fig"} *t*-test comparing ancestral viruses: *t* ~4 ~=~ ~1.389, *P* = 0.237), and plants grow to similar heights when infected with either of these viruses ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1) online; *t*-test comparing plants infected with ancestral viruses: *t* ~4 ~=~ ~0.447, *P* = 0.678). Comparing the evolved lineages, the within-host competitive fitness of the TEV-2b lineages is similar to the lineages of TEV ([fig. 2*A*;](#evw300-F2){ref-type="fig"} Mann--Whitney *U *= 4, *P* = 0.095). In addition, no significant difference in accumulation ([fig. 2*B*;](#evw300-F2){ref-type="fig"} Mann--Whitney *U *= 18, *P* = 0.310) or plant height ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1) online; Mann--Whitney *U *= 8.5, *P* = 0.462) were found between the evolved lineages. All plants infected with TEV or TEV-2b were significantly shorter in height compared with the healthy control plants ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1) online; *t*-test with Holm--Bonferroni correction for multiple tests). These results show that the inserted *2b* gene has no effect on the fitness of TEV.[Fig]{.smallcaps}. 2.---Fitness assays of the ancestral and evolved lineages. (*A*) Within-host competitive fitness (*W*), as determined by competition experiments and RT-qPCR, of TEV and TEV-2b with respect to a common competitor; TEV-eGFP. (*B*) Virus accumulation ($n_{CP}$), as measured by RT-qPCR, of TEV and TEV-2b. (C) Within-host competitive fitness of TEV and TEV-AlkB. (*D*) Virus accumulation of TEV and TEV-AlkB. The ancestral lineages are indicated with light-gray bars and the evolved lineages with dark-gray bars. Both TEV and TEV-2b were evolved for a total of 27 weeks (three 9-week passages), using five replicate lineages for TEV and TEV-2b (L1--L5) and seven replicate lineages (L1--L7) for TEV-AlkB. Evolved lineages that tested significantly different compared with their ancestral virus are indicated with an asterisk (*t*-test with Holm--Bonferroni correction for multiple tests).

All evolved and ancestral lineages were fully sequenced by Illumina technology. The sequences of the ancestral lineages were used as an initial reference for mapping of the evolved lineages. When looking at the genome sequences of the evolved TEV-2b lineages, we find no evidence of convergent adaptive evolution other than for mutations that are also present in the evolved wild-type TEV lineages ([fig. 3*A* and *B*](#evw300-F3){ref-type="fig"}). Nonsynonymous mutation *NIb*/U7262C (amino acid replacement I94T) that appears in 2/10 of the evolved wild-type lineages has not been observed in any of the evolved TEV-2b lineages, suggesting a possible genotype-dependent fitness effect.[Fig]{.smallcaps}. 3.---Genomes of the ancestral and evolved lineages. Mutations were detected using NGS data of the evolved virus lineages as compared with their ancestral lineages. The wild-type TEV is given for comparative purposes. The names on the left identify the virus genotypes and the lineages with their corresponding passage length. The square symbols represent mutations that are fixed (\>50%) and the circle symbols represent mutations that are not fixed (\<50%). Filled symbols represent nonsynonymous substitutions and open symbols represent synonymous substitutions. Black symbols represent substitutions occurring only in one lineage, whereas colored symbols represent substitutions that appear in two or more lineages, or in a lineage from another virus genotype. Note that the mutations are present at different frequencies as reported by SAMtools. Gray boxes indicate genomic deletions in the majority variant.

After remapping the cleaned reads against a newly defined consensus sequence for each lineage, we looked at the variation within each lineage. SNPs were detected from a frequency as low as 1%. In the evolved TEV-2b lineages a total of 507 (390 unique) SNPs were detected, of which 403 were found in the 3-week lineages and 104 in the 9-week lineages, with a median of 30.5 (range, 17--149) per lineage. In the evolved TEV lineages a total of 379 (326 unique) SNPs were detected, of which 188 were found in the 3-week lineages and 191 in the 9-week lineages, with a median of 35 (range, 17--63) per lineage. The distribution of SNPs per gene of the TEV-2b 3-week lineages is different compared with that of the wild-type 3-week lineages (Wilcoxon signed rank test; *V* = 0, *P* = 0.004), where in TEV-2b more SNPs accumulate in all genes (except for *VPg*, where an equal number of SNPs was found). By contrast, the 9-week lineages of TEV-2b accumulated less SNPs in most genes (all except *6K1* and *NIa-Pro*) than the wild-type lineages (Wilcoxon signed rank test; *V* = 61, *P* = 0.014). Interestingly, there is an inverse shift in the amount of synonymous vs. nonsynonymous SNPs when comparing the TEV-2b 3-week (40% synonymous and 60% nonsynonymous) and 9-week lineages (67% synonymous and 33%: nonsynonymous) (Fisher's exact test: *P* \< 0.001), while this shift is not observed in the TEV 3-week (66% synonymous and 34% nonsynonymous) and 9-week (60% synonymous and 40% nonsynonymous) lineages (Fisher's exact test: *P* = 0.464). These differences between the 3-week and 9-week lineages may result from the selective accommodation of the *2b* gene, as we previously observed that selection acts more strongly in the longer-duration passages ([@evw300-B63]). For an overview of the SNP frequency per nucleotide position within the evolved lineages, see [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1) online. For more details on the frequency of the SNPs within every lineage, see [supplementary tables S1 and S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1) online.

The shift of TEV-2b to a similar ratio of synonymous vs. nonsynonymous SNPs as the wild-type might indicate that *2b* is successfully being accommodated in the viral genome. However, an alternative explanation is that the fitness cost of *2b*, which is small in size, is so low that there is little selection for viruses with genomic deletions, and the insert would only be eventually removed by genetic drift. As shown previously, the stability of gene insertions in the TEV genome depends, among other factors, on the position of the insertion ([@evw300-B60]). However, the introduction of two non-functional genes, the colored markers *Ros1* and *eGFP*, at the same genomic position, did lead to instability and the deletion of these markers over evolutionary time ([@evw300-B34]).

Neither the genome sequences of the evolved populations nor the fitness and virulence assays provide evidence that *2b* is actually adaptively accommodated into TEV or performing a function. To directly test whether *2b* is functional and functionally duplicates the silencing suppression activity of HC-Pro when inserted in the TEV genome, we generated mutant genotypes with mutations affecting functional domains of HC-Pro related to RNA silencing suppression. Two different mutant genotypes were considered. One is the so-called FINK mutant, which has an amino acid change (R183I) in the FRNK box in the central region of HC-Pro. The FRNK box is a highly conserved motif within all potyviruses, which is required for sRNA binding and silencing suppression, and this activity is correlated with symptom severity ([@evw300-B45]; [@evw300-B61]). The R183I mutation affects viral pathogenicity and has led to a significant reduction in symptom severity and viral titers in other potyviruses ([@evw300-B18]; [@evw300-B32]; [@evw300-B45]; [@evw300-B27]). The other mutant genotype, AS13, has the E299A and D300A amino acid substitutions ([@evw300-B22]). This mutant has reduced suppressor activity, low accumulation levels, and either does not induce symptoms at all or, in a few cases, mild mottle in *N. benthamiana* plants ([@evw300-B51], [@evw300-B52]).

After generating the FINK and AS13 variants in the TEV and TEV-2b background sequences, we performed infectivity assays in *N. tabacum* plants and scored symptoms at different time points ([fig. 4](#evw300-F4){ref-type="fig"}). At 7 days post inoculation (dpi), all plants infected with TEV, TEV-2b, TEV-2b^FINK^, and TEV-2b^AS13^ viruses display symptoms. The TEV-2b^FINK^ and TEV-2b^AS13^ induce wild-type virus like symptoms in all of the infected plants. Most of the plants infected with TEV^FINK^ and TEV^AS13^ looked similar to healthy plants, although some plants (TEV^FINK^: 4/15; TEV^AS13^: 2/15) did show mild vein clearing in the upper leaves. When comparing the mean time to infection by means of a Kaplan--Meier log-rank test, the symptoms of TEV-2b^AS13^ appear significantly later compared with the wild-type TEV and TEV-2b viruses ([Table 1](#evw300-T1){ref-type="table"}). The symptoms of TEV-2b^FINK^ only appear significantly later compared with the wild-type TEV, but not compared with TEV-2b ([table 1](#evw300-T1){ref-type="table"}). Nevertheless, the difference in the average time to infection between the wild-type TEV and TEV-2b is not significant ([table 1](#evw300-T1){ref-type="table"}).Table 1Kaplan--Meier Log-Rank Test of the FINK and AS13 Infectivity DataGenotypeTEVTEV-2bTEV-2b^FINK^TEV-2b^AS13^χ^2^*P*χ^2^*P*χ^2^*P*χ^2^*P*TEVTEV-2b2.0710.150TEV-2b^FINK^7.2500.0071.5960.206TEV-2b^AS13^16.789\<0.0017.7920.0052.4070.121 [Fig]{.smallcaps}. 4.---Frequency of symptomatic plants infected with the FINK and AS13 virus variants. The *z*-axis represents the cumulative frequency of infection of the TEV^FINK^, TEV-2b^FINK^, TEV^AS13^, and TEV-2b^AS13^ variants in *N. tabacum* plants, as compared with the wild-type TEV and TEV-2b viruses. The different viral genotypes are indicated on the ordinate. Error bars represent the 95% confidence intervals of the estimated frequencies.

Even though TEV^FINK^ and TEV^AS13^ do not induce symptoms in *N. tabacum*, the possibility exists that plants are infected and that these viruses accumulate at low levels. Therefore, RT-PCR and RT-qPCR were used to test if asymptomatic plants inoculated with these two viruses were infected, to confirm the identity of the virus, and to measure accumulation. The HC-Pro region encompassing the FINK and AS13 mutations was amplified by RT-PCR and the mutant genotype of the positive samples was confirmed by Sanger sequencing. The presence or absence of the *2b* gene was also confirmed by amplifying the region encompassing *2b*. We found that 14/15 plants inoculated with TEV^FINK^ were infected with the virus, while only 4/15 plants inoculated with TEV^AS13^ were infected. The viral copy numbers in each plant were measured by RT-qPCR ([fig. 5](#evw300-F5){ref-type="fig"}), and indeed, we found that TEV^FINK^ and TEV^AS13^ accumulate at very low levels. When comparing the RT-qPCR measured viral copy numbers of TEV^FINK^ and TEV-2b^FINK^ as well as of TEV^AS13^ and TEV-2b^AS13^, we found a significant effect of the *HC-Pro* allele present and the plant replicate within each virus genotype (i.e., presence or absence of *2b*) ([table 2](#evw300-T2){ref-type="table"}), indicating that the TEV-2b^FINK^ and TEV-2b^AS13^ accumulate at higher levels compared with the TEV^FINK^ and TEV^AS13^ viruses. By contrast, no significant difference was found when comparing the wild-type TEV and TEV-2b ([table 2](#evw300-T2){ref-type="table"}).Table 2Nested ANOVAs on RT-qPCR Measured Viral Copy NumbersComparisonSource of VariationSSdfMS*FP*TEV^FINK^ vs TEV-2b^FINK^Genotype44.634144.634735.467\<0.001Plant within Genotype1.639270.061145.065\<0.001Error0.024580.000TEV^AS13^ vs TEV-2b^AS13^Genotype24.327124.32741.595\<0.001Plant within Genotype9.358160.5851743.434\<0.001Error0.012360.000TEV vs TEV-2bGenotype0.33410.3342.6650.129Plant within Genotype1.503120.125302.633\<0.001Error0.012280.000 [Fig]{.smallcaps}. 5.---Measured level of infection of the FINK and AS13 variants. RT-qPCR measured virus accumulation ($n_{CP}$) of the TEV^FINK^, TEV-2b^FINK^, TEV^AS13^, and TEV-2b^AS13^ variants. The wild-type TEV and TEV-2b viruses are given for comparative purposes. The numbers above the boxes indicate the number of plants infected over the total number of plants tested. Error bars represent the SD of the mean, whilst circles represent outliers.

The lack of symptoms observed for TEV^FINK^ is consistent with the drastic reduction of symptom severity observed for this mutation in *Zucchini yellow mosaic virus* (ZYMV) in various cucurbit species ([@evw300-B18]). However, in contrast to our results the FINK mutation in ZYMV did not noticeably affect virus accumulation or infectivity ([@evw300-B18]; [@evw300-B45]). In addition, the HC-Pro suppressor activity was not diminished for the ZYMV^FINK^ ([@evw300-B45]). The FINK mutation appears to have different effects on the HC-Pro suppressor activity as this mutation in TEV, *Turnip mosaic virus* (TuMV), and *Potato virus Y* (PVY) did inactivate the HC-Pro suppressor activity ([@evw300-B45]). For the TEV^AS13^ mutant genotype, similar results were obtained in *N. benthamiana* plants, where no symptoms and reduced accumulation levels were observed ([@evw300-B51], [@evw300-B52]). Interestingly, a *Wheat streak mosaic virus* (WSMV) genome lacking the whole *HC-Pro* gene was viable in wheat, oat and corn, producing typical symptoms on all three hosts, however with lower virus titers ([@evw300-B47]). These results indicate that single point mutations can have a similar effect to deleting the whole *HC-Pro*.

These data show that small functional sequences that duplicate a viral function can be maintained in a viral RNA genome. Regardless of whether such a sequence is maintained because it has only a minor fitness cost, or because of second-order evolutionary benefits, functional redundancy therefore could be conducive to evolutionary innovation by ameliorating constraints to virus adaptation that arise due to the rugged topology of the fitness landscape. For example, either the original virus gene or the added gene traverses a fitness valley that had restricted evolution to a local adaptive peak, given that one of the two copies can accumulate deleterious mutations without immediately lowering viral fitness. Gene duplication is often suggested as a mechanism for overcoming such constraints, but for plant viruses gene duplications rarely have been observed. Moreover, duplicated genes ---including *HC-Pro*--- are quickly lost ([@evw300-B60]), suggesting that HGT of smaller sequences providing functional redundancy might be an interesting alternative mechanism.

Introducing a Novel Function into TEV Genome: The *AlkB* Domain
---------------------------------------------------------------

Based on the relative position of the *AlkB* domain within the *P1* gene in BVY, we have introduced the a 2OG-Fe(II) oxygenase *AlkB* domain from *N. benthamiana* into the TEV genome ([fig. 1*C*](#evw300-F1){ref-type="fig"}). The *N. benthamiana* and *N. tabacum AlkB* domains share 97% nucleotide identity. In an attempt to preserve predicted protein secondary structures, the conserved *AlkB* domain was introduced within the *P1* gene without any proteolytic cleavage sites. The TEV-AlkB virus was viable in *N. tabacum* plants, although the symptoms induced were very mild. The expression of *NtAlkB* was higher in uninfected plants, compared with plants infected with TEV ([fig. 6](#evw300-F6){ref-type="fig"}; *t*-test reference gene *L25*: *t* ~4 ~=~ ~9.520, *P* \< 0.001; reference gene *EF-1α*: *t* ~4 ~=~ ~27.592, *P* \< 0.001) or TEV-AlkB ([fig. 6](#evw300-F6){ref-type="fig"}; *t*-test reference gene *L25*: *t* ~4 ~=~ ~4.767, *P* = 0.009; reference gene *EF-1α*: *t* ~4 ~=~ ~13.863, *P* \< 0.001). The plants infected with TEV-AlkB, however, expressed *NtAlkB* at a significantly higher level than plants infected with TEV (*t*-test reference gene *L25*: *t* ~4 ~=~ ~3.305, *P* = 0.030; reference gene *EF-1α*: *t* ~4 ~=~ ~8.775, *P* \< 0.001).[Fig]{.smallcaps}. 6.---Relative *NtAlkB* expression of plants infected with TEV-AlkB. The expression of *NtAlkB* in *N. tabacum* plants was measured by RT-qPCR, relative to the two stable reference genes *L25* (ribosomal protein) and *EF-1α* (elongation factor 1α). Relative expression levels are given in healthy plants, plants infected with the wild-type TEV, and plants infected with TEV-AlkB. Light-gray bars indicate that *L25* was used as a reference, and dark gray bars indicate that *EF-1α* was used.

We then serially passaged the TEV-AlkB virus for 27 weeks, with each passage having a duration of either 3 or 9 weeks. We observed a variety of deletions already in the first passage, when RT-PCR amplifying the region encompassing the *AlkB* domain ([fig. 7](#evw300-F7){ref-type="fig"}). A variety of small deletion variants were observed in the first 3-week passage ([fig. 7*A*](#evw300-F7){ref-type="fig"}), while after a single 9-week passage, there were apparently larger deletions ([fig. 7*B*](#evw300-F7){ref-type="fig"}). At the end of the evolution experiment, all TEV-AlkB lineages contained large deletions within the *AlkB* domain, making it highly unlikely for this domain to remain functional.[Fig]{.smallcaps}. 7.---Detection of deletions after the first passage of TEV-AlkB. Agarose gels with RT-PCR products of the region encompassing the *AlkB* domain. Deletions were detected in lineages (L1--L6) after the first 3-week passage (*A*) and in lineages (L1--L7) of the first 9-week passage (*B*). In both gels, the product sizes of the TEV and TEV-AlkB are shown as a reference, followed by the independent lineages, followed by a healthy control plant.

Next, we measured within-host competitive fitness in direct competition experiments with a fluorescently labeled TEV-eGFP, and we also measured viral accumulation. The introduction of the conserved *AlkB* domain within the TEV genome resulted in a significant decrease in within-host competitive fitness ([fig. 2*C*;](#evw300-F2){ref-type="fig"} *t*-test comparing ancestral viruses: *t* ~4 ~=~ ~7.846, *P* = 0.001) and viral accumulation ([fig. 2*D*;](#evw300-F2){ref-type="fig"} *t*-test comparing ancestral viruses: *t* ~4 ~=~ ~3.587, *P* = 0.023), compared with the wild-type TEV. After 27 weeks of evolution and the occurrence of partial or complete deletions of the *AlkB* domain, both within-host competitive fitness ([fig. 2*C*;](#evw300-F2){ref-type="fig"} comparing evolved lineages: Mann--Whitney *U *= 10, *P* = 0.268) and viral accumulation ([fig. 2*D*;](#evw300-F2){ref-type="fig"} comparing evolved lineages: Mann--Whitney *U *= 18, *P* = 1) were restored to levels similar to the evolved lineages of the wild-type virus.

All evolved and ancestral lineages were fully sequenced by Illumina technology. After an initial mapping step using the ancestral sequence as a reference, the positions of the majority deletions were defined ([fig. 3*C*;](#evw300-F3){ref-type="fig"} see Materials and Methods). Out of 13 evolved lineages, 8 lineages contain deletions within the inserted *AlkB* domain, of which 2 lineages contain an exact deletion of *AlkB*. For the remaining 5 lineages, deletions occurred either upstream (2/13 lineages) or downstream (3/13 lineages) the *AlkB* sequence, thus encompassing part of the *P1* serine protease gene. The P1 proteinase activity is not essential for viral infectivity ([@evw300-B57]); however, the cleavage that separates P1 and HC-Pro is required ([@evw300-B56]). Based on TEV-AlkB infectivity and the fitness data of the evolved lineages, it does not seem that the proteolytic activity of P1 is affected by the deletions observed in this gene.

When mutations were detected in the sequenced lineages, evidence for convergent evolution was found ([fig. 3*C*](#evw300-F3){ref-type="fig"}). A nonsynonymous mutation was found within the *AlkB* domain (U439C, amino acid replacement W10R) in 9/13 evolved lineages. However, in 8/9 lineages this mutation is present in the sequences of the minority deletion variants, in other words, this mutation falls within the deleted region of the majority deletion variant ([fig. 3*C*](#evw300-F3){ref-type="fig"}) and is supported by a low read coverage. Another mutation was found in 12/13 evolved lineages in *VPg* (A6429C). This is a synonymous mutation and is fixed in all 12 lineages, however, this mutation was also found to be fixed within the ancestral population. For more details on the SNPs within every lineage with a frequency \>1%, see [supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw300/-/DC1) online.

The reduction of *NtAlkB* expression in the host plant when infected with TEV suggests that TEV might have a mechanism to suppress the expression of this gene in the host plant. AlkB activity could be beneficial for the host plant as a mechanism of immunity against pathogens like TEV, as it is involved in methylation. The introduction of the conserved *AlkB* domain within the TEV genome does not result in complete silencing of the plant *NtAlkB* gene. On the contrary, TEV-AlkB does not suppress the expression of *NtAlkB* to similar low levels as the wild-type virus does. The higher *NtAlkB* expression in the host plant when infected with TEV-AlkB is likely to be an effect of slower replication of this virus. This is corroborated by the reduced symptomatology, within-host competitive fitness, and viral accumulation of TEV-AlkB. The pseudogenization of the *AlkB* domain confirms that -- for this experimental setup -- this gene is not beneficial for TEV, or that any benefits of *AlkB* are outweighed by the costs.

Conclusion
==========

In this study, we have simulated two independent events of HGT: (i) from an unrelated virus and (ii) from the host species into the genome of TEV. Both inserted genes could provide additional enzymatic activities to the resulting recombinant viruses. Moreover, in the first case, functional redundancy with one of the TEV's own proteins was introduced. We explored the evolutionary fate of the resulting recombinant TEV genomes.

Overall, the results from the first HGT experiment strongly suggest that the *2b* gene from CMV can compensate for what would otherwise be deleterious mutations in HC-Pro. Therefore, it seems reasonable to conclude that *2b* exhibits VSR activity as a transgene in TEV, to the extent that it can compensate for the hypo-suppression of the AS13 and FINK mutants. Even though symptoms develop more slowly, infection is similar to both the TEV-2b^FINK^ and TEV-2b^AS13^ genotypes 10 dpi. There are therefore two possible evolutionary mechanisms to explain these results. First, although the 2b protein has been shown to be functional in TEV-2b, it could still not be beneficial and at the same time have a small fitness cost. In this case, the gene would be maintained during the evolution experiment due to (i) a limited mutational supply of large genomic deletions that conserve polyprotein processing, (ii) weak selection for these mutants, and (iii) periodic bottlenecks during horizontal transmissions that reduce the efficiency of selection of slightly beneficial deletions. Second, our results with the HC-Pro mutants show that the functional redundancy provided by 2b may, in principle, increase the mutational robustness of the VSR activity. Therefore, *2b* could be maintained because it contributes to buffering the effects of deleterious mutations in the silencing suppressor region of HC-Pro.

In contrast to the observed evolutionary stability of the *2b* gene, the simulated HGT of the *AlkB* domain from *Nicotiana* into the TEV genome turns out to be highly unstable. It has been reported that the *E. coli* and human homologs of *AlkB* are able to repair both alkylated ssDNA and ssRNA substrates *in vitro* ([@evw300-B58]), however it is not known whether the plant homolog shares this lack of substrate specificity. The absence of a preference for ssRNA as a substrate possibly could explain why the inserted *NtAlkB* domain is not maintained within the TEV genome. Another explanation for deletion of this domain is that it has very low similarity to the *AlkB* domain found in BVY, the only other potyvirus that carries this domain. Furthermore, the *AlkB* domain in BVY has homologous domains in other plant viruses (e.g., *Flexiviridae*), and the similarity between these is higher than the similarity of BVY P1 orthologs in other potyviruses ([@evw300-B49]). Therefore, it is more likely that BVY has obtained this domain through a HGT event from another virus rather than from its host. A similar experimental setup but with the *AlkB* domain from BVY inserted into TEV might potentially lead to different results, resulting in the maintenance and accommodation of this gene.

In conclusion, HGT events may contribute to increases in the genome complexity of RNA viruses, but the evolutionary outcome of such events would hardly be predictable. Adding new functions does not necessarily result in retaining the novel gene.
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